Michael Fernandes de Almeida, PhD | Pharmacology
Michael Fernandes de Almeida, PhD| Pharmacology
Dr. Stringer holds appointments in both the School of Medicine (OBGYN) and the Gillings School of Global Public Health (Epidemiology). He also serves as Associate Director for Research within UNC’s Institute for Global Health and Infectious Diseases. Between 2001 and 2012, Stringer lived in Lusaka, Zambia, where he co-founded and led the Centre for Infectious Disease Research in Zambia (CIDRZ). Stringer’s current research focuses on developing and evaluating new technologies to improve ob...| www.med.unc.edu
Research Interests Key words: Rare Disease, Real World Data, Ontologies, Semantics, Precision Medicine Lab Website Translational science breaks down traditional silos between scientific disciplines, empowering research innovation and implementation in biomedicine. The Translational and Integrative Sciences Laboratory (TISLab) applies semantic engineering technologies to these varied disciplines to understand the relationship between phenotypes, genetic endowment, and … Read more| Department of Genetics
Kimberly Enders is a Senior Research Scientist in the Biostatistics department at UNC. She has over 10 years of collaborative public health research experience spanning a wide range of topics including HIV, COVID-19, and other infectious diseases. She received her DrPH in biostatistics from the UNC Gillings School of Global Public Health where her research focused on Bayesian approaches to address missing data and analysis challenges in the setting of longitudinal studies with frequent measur...| UNC Center for AIDS Research
The UNC CFAR is to provide infrastructure to support investigation of the HIV/AIDS epidemic using clinical research, behavioral research, research into HIV biology and pathogenesis at the molecular level, and educational outreach.| UNC Center for AIDS Research
A University of North Carolina at Chapel Hill clinical trial found that graphic health warnings on little cigars and cigarillos significantly increase users’ intentions to quit and promote behaviors linked to tobacco cessation. These findings could provide the cigar-specific evidence the FDA previously lacked in efforts to require cigar warnings. Published in JAMA Network Open, … Read more| Department of Family Medicine
